NCT00263159

Brief Summary

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
221

participants targeted

Target at P75+ for not_applicable asthma

Timeline
Completed

Started Jan 2006

Shorter than P25 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 7, 2005

Completed
25 days until next milestone

Study Start

First participant enrolled

January 1, 2006

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2006

Completed
Last Updated

December 28, 2007

Status Verified

December 1, 2007

First QC Date

December 6, 2005

Last Update Submit

December 19, 2007

Conditions

Asthma

Outcome Measures

Primary Outcomes (1)

  • The difference between study groups in the change of asthma control from baseline and follow-up visits

    after 1, 3 and 6 months

Secondary Outcomes (9)

  • Peak flow

    after 3 and 6 months

  • Knowledge of asthma and treatment

    after 6 months

  • Asthma quality of life questionnaire (AQLQ)

    after 6 months

  • Therapy adherence

  • Inhalation techniques

    after 6 months

  • +4 more secondary outcomes

Interventions

Pharmaceutical care for asthma patientsPROCEDURE

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with persistent asthma
  • Asthma treatment for at least 12 months
  • Regular visitors of the participating community pharmacy

You may not qualify if:

  • Severe co-morbidity
  • \> 10 pack-years smoking history
  • Asthma Control Test score \< 15 or =25

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

MeSH Terms

Conditions

Asthma

Interventions

Pharmaceutical Services

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Health ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Guy Brusselle, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 6, 2005

First Posted

December 7, 2005

Study Start

January 1, 2006

Study Completion

October 1, 2006

Last Updated

December 28, 2007

Record last verified: 2007-12

Locations

BE(1)